nodes	percent_of_prediction	percent_of_DWPC	metapath
Encainide—CYP2D6—breast cancer	0.704	1	CbGaD
Encainide—CYP2D6—Idarubicin—breast cancer	0.0965	0.414	CbGbCtD
Encainide—CYP2D6—Vinorelbine—breast cancer	0.0471	0.202	CbGbCtD
Encainide—CYP2D6—Tamoxifen—breast cancer	0.0425	0.183	CbGbCtD
Encainide—CYP2D6—Vinblastine—breast cancer	0.029	0.125	CbGbCtD
Encainide—CYP2D6—Doxorubicin—breast cancer	0.0178	0.0766	CbGbCtD
Encainide—Bezafibrate—SLCO1B1—breast cancer	0.00163	0.173	CrCbGaD
Encainide—Zafirlukast—ABCG2—breast cancer	0.00105	0.111	CrCbGaD
Encainide—Zafirlukast—PTGS1—breast cancer	0.000901	0.0953	CrCbGaD
Encainide—Zafirlukast—CYP2D6—breast cancer	0.000613	0.0649	CrCbGaD
Encainide—Clemastine—CYP2D6—breast cancer	0.000557	0.0589	CrCbGaD
Encainide—Bezafibrate—CYP1A1—breast cancer	0.000557	0.0589	CrCbGaD
Encainide—Eletriptan—PTGS1—breast cancer	0.000553	0.0585	CrCbGaD
Encainide—Zafirlukast—CYP3A4—breast cancer	0.000526	0.0556	CrCbGaD
Encainide—Clemastine—CYP3A4—breast cancer	0.000478	0.0505	CrCbGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—FOXM1—breast cancer	0.000425	0.00799	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—ARTN—breast cancer	0.000425	0.00798	CbGpPWpGaD
Encainide—CYP2D6—Tamoxifen metabolism—CYP1B1—breast cancer	0.000424	0.00797	CbGpPWpGaD
Encainide—SCN5A—Cardiac Progenitor Differentiation—KDR—breast cancer	0.000419	0.00786	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—PAK1—breast cancer	0.000418	0.00786	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—EFNA1—breast cancer	0.000412	0.00775	CbGpPWpGaD
Encainide—CYP2D6—Melatonin metabolism and effects—ACHE—breast cancer	0.000411	0.00773	CbGpPWpGaD
Encainide—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—breast cancer	0.0004	0.00751	CbGpPWpGaD
Encainide—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—breast cancer	0.000394	0.00741	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—NTN4—breast cancer	0.000388	0.0073	CbGpPWpGaD
Encainide—SCN5A—Cardiac Progenitor Differentiation—KIT—breast cancer	0.000386	0.00724	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—NRCAM—breast cancer	0.000383	0.0072	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.000383	0.00719	CbGpPWpGaD
Encainide—Eletriptan—CYP2D6—breast cancer	0.000376	0.0398	CrCbGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.000361	0.00679	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—EBF1—breast cancer	0.000361	0.00678	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—RANBP9—breast cancer	0.000361	0.00678	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—HNF4G—breast cancer	0.000361	0.00678	CbGpPWpGaD
Encainide—Bezafibrate—CYP3A4—breast cancer	0.000355	0.0376	CrCbGaD
Encainide—SCN5A—Cardiac Progenitor Differentiation—IGF1—breast cancer	0.000353	0.00663	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SCN10A—breast cancer	0.000342	0.00642	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—EVL—breast cancer	0.000339	0.00638	CbGpPWpGaD
Encainide—CYP2D6—Xenobiotics—CYP1A1—breast cancer	0.000334	0.00628	CbGpPWpGaD
Encainide—CYP2D6—Melatonin metabolism and effects—CYP1B1—breast cancer	0.000328	0.00616	CbGpPWpGaD
Encainide—Eletriptan—CYP3A4—breast cancer	0.000323	0.0341	CrCbGaD
Encainide—CYP2D6—Tamoxifen metabolism—CYP1A1—breast cancer	0.000322	0.00604	CbGpPWpGaD
Encainide—Diltiazem—CYP2D6—breast cancer	0.00032	0.0338	CrCbGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—ALDH1A1—breast cancer	0.000317	0.00596	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—GATA3—breast cancer	0.000316	0.00593	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—EPHB4—breast cancer	0.000307	0.00577	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—EFNA1—breast cancer	0.000294	0.00553	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—ESR2—breast cancer	0.000284	0.00533	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—FGFR1—breast cancer	0.000276	0.00519	CbGpPWpGaD
Encainide—Diltiazem—CYP3A4—breast cancer	0.000274	0.029	CrCbGaD
Encainide—SCN5A—Developmental Biology—NRCAM—breast cancer	0.000274	0.00514	CbGpPWpGaD
Encainide—Eletriptan—ABCB1—breast cancer	0.000269	0.0284	CrCbGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—EGR1—breast cancer	0.000265	0.00498	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—ANGPTL4—breast cancer	0.000257	0.00483	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—AR—breast cancer	0.000251	0.00471	CbGpPWpGaD
Encainide—Mesoridazine—CYP2D6—breast cancer	0.00025	0.0265	CrCbGaD
Encainide—SCN5A—Developmental Biology—WNT10B—breast cancer	0.00025	0.0047	CbGpPWpGaD
Encainide—CYP2D6—Melatonin metabolism and effects—CYP1A1—breast cancer	0.000248	0.00467	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SCN10A—breast cancer	0.000244	0.00458	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CHST9—breast cancer	0.000242	0.00456	CbGpPWpGaD
Encainide—Diltiazem—ABCB1—breast cancer	0.000228	0.0242	CrCbGaD
Encainide—SCN5A—Axon guidance—CFL1—breast cancer	0.000228	0.00428	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—HES1—breast cancer	0.00022	0.00414	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—breast cancer	0.000218	0.00409	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—breast cancer	0.000215	0.00404	CbGpPWpGaD
Encainide—SCN5A—Cardiac Progenitor Differentiation—TGFB1—breast cancer	0.000212	0.00398	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—NCOA2—breast cancer	0.000207	0.0039	CbGpPWpGaD
Encainide—Thioridazine—CYP2D6—breast cancer	0.000189	0.02	CrCbGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—breast cancer	0.000186	0.0035	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—HIF1A—breast cancer	0.000185	0.00347	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—breast cancer	0.000184	0.00345	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	0.000183	0.00344	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—breast cancer	0.000181	0.0034	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	0.000176	0.00331	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	0.000175	0.00328	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	0.000175	0.00328	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	0.000172	0.00324	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—breast cancer	0.00017	0.00319	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—ALDH1A1—breast cancer	0.000169	0.00317	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	0.000168	0.00316	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CFL1—breast cancer	0.000163	0.00306	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—PAK1—breast cancer	0.000158	0.00297	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MED12—breast cancer	0.000155	0.0029	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—breast cancer	0.000151	0.00284	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTA3—breast cancer	0.00015	0.00282	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—HSP90AA1—breast cancer	0.00015	0.00281	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	0.000149	0.00279	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GSTA3—breast cancer	0.000148	0.00278	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—NCOA3—breast cancer	0.000148	0.00278	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—WNT1—breast cancer	0.000148	0.00278	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SRC—breast cancer	0.000147	0.00277	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SLC2A2—breast cancer	0.000147	0.00276	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—ADAM10—breast cancer	0.000144	0.0027	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	0.000142	0.00266	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	0.00014	0.00262	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	0.000139	0.00261	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTA4—breast cancer	0.000137	0.00258	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—breast cancer	0.000137	0.00257	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—MAPK3—breast cancer	0.000136	0.00255	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GSTA4—breast cancer	0.000135	0.00254	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTA2—breast cancer	0.000134	0.00251	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—SULT1A1—breast cancer	0.000132	0.00248	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GPX2—breast cancer	0.000132	0.00248	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—SULT1A1—breast cancer	0.00013	0.00245	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GPX4—breast cancer	0.00013	0.00245	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—ABL1—breast cancer	0.00013	0.00244	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTA1—breast cancer	0.000129	0.00243	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—EGFR—breast cancer	0.000129	0.00242	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—NAT2—breast cancer	0.000128	0.0024	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—NAT2—breast cancer	0.000126	0.00237	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—NCOA2—breast cancer	0.000123	0.00232	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CXCL8—breast cancer	0.00012	0.00225	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—IL1B—breast cancer	0.000115	0.00216	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CASP3—breast cancer	0.000115	0.00215	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—PAK1—breast cancer	0.000113	0.00212	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	0.000113	0.00211	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—JUN—breast cancer	0.000111	0.00209	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—breast cancer	0.00011	0.00208	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—HSP90AA1—breast cancer	0.000107	0.00201	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—FGFR1—breast cancer	0.000104	0.00196	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—MTR—breast cancer	0.000104	0.00196	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—NCOA1—breast cancer	0.000104	0.00195	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—ADAM10—breast cancer	0.000102	0.00192	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—HPGDS—breast cancer	0.000102	0.00192	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—FGF10—breast cancer	9.96e-05	0.00187	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTT1—breast cancer	9.9e-05	0.00186	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—KDR—breast cancer	9.84e-05	0.00185	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—VEGFA—breast cancer	9.73e-05	0.00183	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—MET—breast cancer	9.63e-05	0.00181	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP17A1—breast cancer	9.37e-05	0.00176	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—PTGS1—breast cancer	9.28e-05	0.00174	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—ABL1—breast cancer	9.26e-05	0.00174	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP17A1—breast cancer	9.24e-05	0.00174	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SMAD4—breast cancer	8.97e-05	0.00169	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—NCOA2—breast cancer	8.93e-05	0.00168	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—HES1—breast cancer	8.76e-05	0.00165	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—NCOR1—breast cancer	8.71e-05	0.00164	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—TNF—breast cancer	8.33e-05	0.00157	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—MMP2—breast cancer	8.03e-05	0.00151	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP3A4—breast cancer	8.03e-05	0.00151	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP3A4—breast cancer	7.92e-05	0.00149	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP1B1—breast cancer	7.89e-05	0.00148	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP1B1—breast cancer	7.78e-05	0.00146	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—NCOA1—breast cancer	7.53e-05	0.00141	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—FGFR1—breast cancer	7.45e-05	0.0014	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP19A1—breast cancer	7.42e-05	0.00139	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP19A1—breast cancer	7.32e-05	0.00137	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—LEP—breast cancer	7.17e-05	0.00135	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—RAF1—breast cancer	7.11e-05	0.00134	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—ERBB2—breast cancer	7.04e-05	0.00132	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—KDR—breast cancer	7.02e-05	0.00132	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—COMT—breast cancer	6.9e-05	0.0013	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CDK4—breast cancer	6.87e-05	0.00129	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MET—breast cancer	6.87e-05	0.00129	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTP1—breast cancer	6.86e-05	0.00129	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—COMT—breast cancer	6.8e-05	0.00128	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GSTP1—breast cancer	6.77e-05	0.00127	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—IL6—breast cancer	6.73e-05	0.00126	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—NOTCH1—breast cancer	6.61e-05	0.00124	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—GSTM1—breast cancer	6.31e-05	0.00118	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—GSTM1—breast cancer	6.22e-05	0.00117	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—MMP9—breast cancer	6.04e-05	0.00113	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP1A1—breast cancer	5.98e-05	0.00112	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—AKT2—breast cancer	5.92e-05	0.00111	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP1A1—breast cancer	5.9e-05	0.00111	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MMP2—breast cancer	5.73e-05	0.00108	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SRC—breast cancer	5.56e-05	0.00105	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—VEGFA—breast cancer	5.42e-05	0.00102	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—MAPK3—breast cancer	5.13e-05	0.000963	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—RAF1—breast cancer	5.08e-05	0.000953	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—RELA—breast cancer	5.05e-05	0.000949	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—ERBB2—breast cancer	5.02e-05	0.000943	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—EGFR—breast cancer	4.88e-05	0.000916	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SYNJ2—breast cancer	4.81e-05	0.000904	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—KRAS—breast cancer	4.61e-05	0.000865	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NDUFS3—breast cancer	4.47e-05	0.00084	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CTNNB1—breast cancer	4.39e-05	0.000825	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MMP9—breast cancer	4.31e-05	0.000809	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CHST9—breast cancer	4.2e-05	0.00079	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—COX11—breast cancer	3.99e-05	0.000749	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SRC—breast cancer	3.97e-05	0.000746	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—HRAS—breast cancer	3.92e-05	0.000736	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—VEGFA—breast cancer	3.87e-05	0.000726	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—STAT3—breast cancer	3.83e-05	0.000719	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—IL6—breast cancer	3.75e-05	0.000704	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MAPK3—breast cancer	3.66e-05	0.000687	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SHMT1—breast cancer	3.65e-05	0.000685	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CDA—breast cancer	3.65e-05	0.000685	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—TGFB1—breast cancer	3.55e-05	0.000667	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLC2A5—breast cancer	3.51e-05	0.000659	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLCO1B1—breast cancer	3.51e-05	0.000659	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—EGFR—breast cancer	3.48e-05	0.000654	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—APRT—breast cancer	3.39e-05	0.000637	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—TNF—breast cancer	3.31e-05	0.000623	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—KRAS—breast cancer	3.29e-05	0.000618	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ANGPTL4—breast cancer	3.19e-05	0.000599	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ESRRA—breast cancer	3.19e-05	0.000599	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HADHB—breast cancer	3.02e-05	0.000567	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GPI—breast cancer	3.02e-05	0.000567	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ALDH7A1—breast cancer	2.88e-05	0.000541	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ALDH1A1—breast cancer	2.88e-05	0.000541	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—HRAS—breast cancer	2.79e-05	0.000525	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PHGDH—breast cancer	2.76e-05	0.000519	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—UMPS—breast cancer	2.76e-05	0.000519	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—FHL2—breast cancer	2.76e-05	0.000519	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ADSL—breast cancer	2.76e-05	0.000519	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NME1—breast cancer	2.76e-05	0.000519	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HPSE—breast cancer	2.71e-05	0.000509	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—BRIP1—breast cancer	2.71e-05	0.000509	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—LDHB—breast cancer	2.71e-05	0.000509	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—IL6—breast cancer	2.67e-05	0.000502	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTA3—breast cancer	2.57e-05	0.000482	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ABCC1—breast cancer	2.57e-05	0.000482	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HMMR—breast cancer	2.57e-05	0.000482	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PPARGC1B—breast cancer	2.49e-05	0.000467	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—AKT1—breast cancer	2.47e-05	0.000464	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTA4—breast cancer	2.35e-05	0.000441	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CA9—breast cancer	2.35e-05	0.000441	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GPX2—breast cancer	2.29e-05	0.00043	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTA2—breast cancer	2.29e-05	0.00043	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GPX4—breast cancer	2.26e-05	0.000425	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SULT1A1—breast cancer	2.26e-05	0.000425	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—IDH1—breast cancer	2.21e-05	0.000415	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTA1—breast cancer	2.21e-05	0.000415	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NAT2—breast cancer	2.18e-05	0.00041	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—DPYD—breast cancer	1.92e-05	0.00036	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—MED12—breast cancer	1.92e-05	0.00036	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ALDOA—breast cancer	1.89e-05	0.000354	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NCOA3—breast cancer	1.83e-05	0.000344	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLC2A2—breast cancer	1.82e-05	0.000341	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CPT1A—breast cancer	1.78e-05	0.000334	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—MTR—breast cancer	1.78e-05	0.000334	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ABCG2—breast cancer	1.78e-05	0.000334	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HPGDS—breast cancer	1.75e-05	0.000328	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HBA1—breast cancer	1.74e-05	0.000326	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ACHE—breast cancer	1.69e-05	0.000318	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTT1—breast cancer	1.69e-05	0.000318	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP17A1—breast cancer	1.6e-05	0.000301	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ENO1—breast cancer	1.59e-05	0.000298	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PTGS1—breast cancer	1.59e-05	0.000298	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NCOA2—breast cancer	1.53e-05	0.000287	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—FASN—breast cancer	1.48e-05	0.000278	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—BCHE—breast cancer	1.48e-05	0.000277	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLC5A5—breast cancer	1.46e-05	0.000274	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NQO1—breast cancer	1.41e-05	0.000264	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLC2A1—breast cancer	1.41e-05	0.000264	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP3A4—breast cancer	1.37e-05	0.000258	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP1B1—breast cancer	1.35e-05	0.000253	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.32e-05	0.000249	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NCOA1—breast cancer	1.29e-05	0.000242	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—STK11—breast cancer	1.27e-05	0.000238	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP19A1—breast cancer	1.27e-05	0.000238	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—COMT—breast cancer	1.18e-05	0.000222	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTP1—breast cancer	1.17e-05	0.00022	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HMOX1—breast cancer	1.16e-05	0.000217	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ITPR1—breast cancer	1.16e-05	0.000217	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ABCB1—breast cancer	1.11e-05	0.000209	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—TYMS—breast cancer	1.09e-05	0.000205	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.08e-05	0.000203	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GSTM1—breast cancer	1.08e-05	0.000203	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NCOR1—breast cancer	1.08e-05	0.000203	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GPX1—breast cancer	1.03e-05	0.000194	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP1A1—breast cancer	1.02e-05	0.000192	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ERCC2—breast cancer	1.01e-05	0.000191	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—MTHFR—breast cancer	9.53e-06	0.000179	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CAV1—breast cancer	8.79e-06	0.000165	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PIK3CG—breast cancer	8.01e-06	0.00015	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PIK3CD—breast cancer	7.04e-06	0.000132	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ALB—breast cancer	6.95e-06	0.000131	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NOS3—breast cancer	6.65e-06	0.000125	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PIK3CB—breast cancer	6.14e-06	0.000115	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PTGS2—breast cancer	6.08e-06	0.000114	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PTEN—breast cancer	5.3e-06	9.96e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PIK3CA—breast cancer	3.74e-06	7.03e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—AKT1—breast cancer	3.06e-06	5.74e-05	CbGpPWpGaD
